NCT01848210View on ClinicalTrials.gov

Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous Insufficiency

PHASE4CompletedINTERVENTIONAL
Enrollment

829

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Chronic Venous Insufficiency
Interventions
DRUG

Coumarin/troxerutin

Coumarin + troxerutin fixed-dose combination tablets

DRUG

Placebo

Coumarin + troxerutin placebo-matching tablets

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01848210 - Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous Insufficiency | Biotech Hunter | Biotech Hunter